Development of highly potent non-covalent inhibitors of SARS-CoV-2 3CLpro
N. Hou, L. Shuai, L. Zhang, X. Xie, K. Tang, Y. Zhu, Y. Yu, W. Zhang, Q. Tan, G. Zhong, Z. Wen, C. Wang, X. He, H. Huo, H. Gao, , Q. Hu
This study develops a potent non-covalent inhibitor of SARS-CoV-2 3CLpro, showing effective antiviral activity in human cells and animal models.
bioRxiv · Aug 10, 2022 · PreprintMicrobiology